Clinical trial
A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation Study of NPT088 in Patients With Probable Alzheimer's Disease
NCT03008161 is registered in ClinicalTrials.gov with Proclara Biosciences, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Dose Escalation Study of NPT088 in Patients With Probable Alzheimer's Disease
- Lead sponsor
- Proclara Biosciences, Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2016
- Completion date
- February 6, 2019
- Enrollment
- 83 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.